Aoyang Technology was approved by the Jiangsu Provincial People's Government.
Jiangsu Aoyang Technology Co., Ltd. is a subsidiary of China Fortune 500, a Fortune 500 company. It was established in September 2001 and is a listed private joint-stock company. It is located in the southern part of Zhangjiagang Economic Development Zone and has nearly 5,000 employees. people.In May 2015, Aoyang Health, a key member of the Aoyang Group, was injected into Aoyang Technology as a quality asset and became a wholly-owned subsidiary. At present, Aoyang Technology has two core businesses of chemical fiber and medical health, and has a fiber division, a medical division, a rehabilitation division, and a circulation division.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 14, 2019
Genechem (China)
|
Series C | — | Biotechnology | — |
Jan 5, 2016
Genechem (China)
|
Series B | ¥100M | Biotechnology | — |